Iradimed (NASDAQ:IRMD) Upgraded at StockNews.com
StockNews.com upgraded shares of Iradimed (NASDAQ:IRMD – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Friday. Separately, Roth Mkm reaffirmed a “buy” rating and set a $72.00 target price (up previously from $60.00) on shares of Iradimed in a research report on Friday, February 14th. […]
StockNews.com upgraded shares of Iradimed (NASDAQ:IRMD – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Friday. Separately, Roth Mkm reaffirmed a “buy” rating and set a $72.00 target price (up previously from $60.00) on shares of Iradimed in a research report on Friday, February 14th. […]
